Transcend Capital Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,900
| Closed | -$206K | – | 608 |
|
|
2024
Q3 | $206K | Sell |
21,900
-600
| -3% | -$5.63K | 0.01% | 577 |
|
|
2024
Q2 | $180K | Buy |
+22,500
| New | +$180K | 0.01% | 568 |
|
|
2021
Q2 | – | Sell |
-6,830
| Closed | -$216K | – | 362 |
|
|
2021
Q1 | $216K | Sell |
6,830
-2,250
| -25% | -$71.2K | 0.03% | 371 |
|
|
2020
Q4 | $421K | Buy |
9,080
+236
| +3% | +$10.9K | 0.06% | 253 |
|
|
2020
Q3 | $291K | Buy |
+8,844
| New | +$291K | 0.05% | 210 |
|